Clinical trial
Efficacy and Safety of Double Plasma Cytokine Adsorption System With Sequential Low-Dose Plasma Exchange in Treating Acute-on-Chronic Liver Failure and Sepsis: A Multi-center Randomized Controlled Study
NCT06562803 is registered in ClinicalTrials.gov with Third Affiliated Hospital, Sun Yat-Sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Double Plasma Cytokine Adsorption System With Sequential Low-Dose Plasma Exchange in Treating Acute-on-Chronic Liver Failure and Sepsis: A Multi-center Randomized Controlled Study
- Lead sponsor
- Third Affiliated Hospital, Sun Yat-Sen University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 27, 2024
- Completion date
- December 31, 2027
- Enrollment
- 192 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.